Efficacy and safety of once?weekly subcutaneous semaglutide 2.4 mg for the management of overweight or obesity in Asian populations: A systematic review, meta?analysis and meta â¦
Publication Name : Diabetes, Obesity and Metabolism 27 (11), 6632-6643, 2025
Citation : 2
Date : 2025